Acadia Pharmaceuticals (ACAD) Other Working Capital Changes (2016 - 2025)
Acadia Pharmaceuticals (ACAD) has 16 years of Other Working Capital Changes data on record, last reported at -$1.3 million in Q4 2025.
- For Q4 2025, Other Working Capital Changes fell 117.48% year-over-year to -$1.3 million; the TTM value through Dec 2025 reached $3.8 million, up 3386.32%, while the annual FY2025 figure was $3.8 million, 3386.32% up from the prior year.
- Other Working Capital Changes reached -$1.3 million in Q4 2025 per ACAD's latest filing, down from $6.6 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $7.7 million in Q4 2024 and bottomed at -$14.8 million in Q3 2024.
- Average Other Working Capital Changes over 5 years is -$503500.0, with a median of -$567500.0 recorded in 2021.
- The widest YoY moves for Other Working Capital Changes: up 321.62% in 2024, down 17680.72% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at $1.1 million in 2021, then plummeted by 760.73% to -$7.0 million in 2022, then grew by 15.86% to -$5.9 million in 2023, then soared by 230.01% to $7.7 million in 2024, then plummeted by 117.48% to -$1.3 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Working Capital Changes were -$1.3 million in Q4 2025, $6.6 million in Q3 2025, and $1.6 million in Q2 2025.